Informed consent and tardive dyskinesia. Long-term follow-up

Journal of Nervous and Mental Disease

Volumn 184, Issue 9, 1996, Pages 517-522

  Kleinman, Irwin ^a,b   Schachter, Debbie ^b   Jeffries, Joel ^b   Goldhamer, Paul ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INFORMED CONSENT; MALE; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EMPIRICAL APPROACH; MENTAL HEALTH THERAPIES; PROFESSIONAL PATIENT RELATIONSHIP;

ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; DYSKINESIA, DRUG-INDUCED; FOLLOW-UP STUDIES; HUMANS; INFORMED CONSENT; PATIENT EDUCATION; PATIENT PARTICIPATION; QUESTIONNAIRES; RISK ASSESSMENT; SCHIZOPHRENIA;

EID: 0029786689     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005053-199609000-00001     Document Type: Article

References (14)

1. American Psychiatric Association Task Force on Late Neurological Effects of Antipsychotic Drugs (1980) Tardive dyskinesia: Summary of a task force report of the American Psychiatric Association. Am J Psychiatry 137:1163-1172.
2. Beauchamp TL, Childress JF (1989) Principles of biomedical ethics, 3rd ed. New York: Oxford University Press.
3. Davis JM (1975) Overview: Maintenance therapy in psychiatry. I. Schizophrenia. Am J Psychiatry 132:1237-1245.
4. Grossman L, Summers F (1980) A study of the capacity of schizophrenic patients to give informed consent. Hosp Community Psychiatry 31:205-206.
5. Jeste DV, Wyatt RJ (1982) Understanding and treating tardive dyskinesia. New York: Guilford.
6. Jonsen AR, Siegler M, Winslade WJ (1986) Clinical ethics: A practical approach to ethical decisions in clinical medicine, 2nd ed. New York: MacMillan.
7. Kane JM Smith JA (1982) Tardive dyskinesia: Prevalence and risk factors, 1959-1979. Arch Gen Psychiatry 39:472-481.
8. Kleinman I, Schachter D, Jeffries J, Goldhamer P (1993) Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication. Hosp Community Psychiatry 44(12):1189-1191.
9. Kleinman I, Schachter D, Koritar E (1989) Informed consent and tardive dyskinesia. Am J Psychiatry 146:902-904.
10. Meisel A, Roth LH, Lidz CW (1977) Toward a model of the legal doctrine of informed consent. Am J Psychiatry 134:285-289.
11. Munetz MR, Roth LH (1985) Informing patients about tardive dyskinesia. Arch Gen Psychiatry 42:866-871.
12. Pellegrino ED, Thomasma DC (1988) For the patient's good: The restoration of beneficence in health care. New York: Oxford University Press.
13. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (October, 1982) Making health care decisions: A report on the ethical and legal implications of informed consent in the patient-practitioner relationship, vol I, Washington, DC: Government Printing Office.
14. Schachter D, Kleinman I, Prendergast P, Remington G, Schertzer S (1994) Effect of psychopathology on informed consent. J Nerv Ment Dis 182:360-262.